首页 > 最新文献

Archives of Surgery最新文献

英文 中文
Image of the month-diagnosis. 月诊断图像。
Pub Date : 2012-09-01 DOI: 10.1001/archsurg.147.9.888
{"title":"Image of the month-diagnosis.","authors":"","doi":"10.1001/archsurg.147.9.888","DOIUrl":"https://doi.org/10.1001/archsurg.147.9.888","url":null,"abstract":"","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":"888"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archsurg.147.9.888","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31495520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selective preoperative magnetic resonance imaging in women with breast cancer: no reduction in the reoperation rate. 乳腺癌妇女术前选择性磁共振成像:未降低再手术率。
Pub Date : 2012-09-01 DOI: 10.1001/archsurg.2012.1660
Joseph J Weber, Lisa S Bellin, David E Milbourn, Kathryn M Verbanac, Jan H Wong

Hypothesis: The use of preoperative magnetic resonance (MR) imaging may have an effect on the reoperation rate in women with operable breast cancer.

Design: Retrospective cohort study.

Setting: University medical center.

Patients: Women with operable breast cancer treated by a single surgeon between January 1, 2006, and December 31, 2010.

Intervention: Selective preoperative MR imaging based on breast density and histologic findings.

Main outcome measures: Reoperation rate and pathologically avoidable mastectomy at initial operation.

Results: Of 313 patients in the study, 120 underwent preoperative MR imaging. Patients undergoing MR imaging were younger (mean age, 53.6 vs 59.5 years; P < .001), were more often of non-Hispanic white race/ethnicity (61.7% vs 52.3%, P < .05), and more likely had heterogeneously dense or very dense breasts (68.4% vs 22.3%, P < .001). The incidence of lobular carcinoma (8.3% in the MR imaging group vs 5.2% in the no MR imaging group, P = .27) and the type of surgery performed (mastectomy vs partial mastectomy, P = .67) were similar in both groups. The mean pathological size of the index tumor in the MR imaging group was larger than that in the no MR imaging group (2.02 vs 1.72 cm, P = .009), but the extent of disease was comparable (75.8% in the MR imaging group vs 82.9% in the no MR imaging group had pathologically localized disease, P = .26). The reoperation rate was similar between the 2 groups (19.1% in the MR imaging group vs 17.6% in the no MR imaging group, P = .91) even when stratified by breast density (P = .76), pT2 tumor size (P = .35), or lobular carcinoma histologic findings (P = .26). Pathologically avoidable mastectomy (multifocal or multicentric MR imaging and unifocal histopathological findings) was observed in 12 of 47 patients (25.5%) with preoperative MR imaging who underwent mastectomy.

Conclusion: The selective use of preoperative MR imaging to decrease reoperation in women with breast cancer is not supported by these data. In a considerable number of patients, MR imaging overestimates the extent of disease.

假设:术前磁共振(MR)成像可能对可手术乳腺癌患者的再手术率有影响。设计:回顾性队列研究。地点:大学医疗中心。患者:2006年1月1日至2010年12月31日期间接受单一外科医生治疗的可手术乳腺癌患者。干预:术前选择性磁共振成像基于乳腺密度和组织学表现。主要观察指标:术后再手术率及病理可避免的乳房切除术。结果:在研究的313例患者中,120例接受了术前磁共振成像。接受磁共振成像的患者更年轻(平均年龄,53.6 vs 59.5岁;P < .001),非西班牙裔白人/族裔(61.7%对52.3%,P < .05),更可能患有异质性致密或非常致密的乳房(68.4%对22.3%,P < .001)。两组小叶癌的发生率(磁共振成像组为8.3%,无磁共振成像组为5.2%,P = 0.27)和手术类型(乳房切除术与部分乳房切除术,P = 0.67)相似。磁共振成像组指数肿瘤的平均病理大小大于无磁共振成像组(2.02 vs 1.72 cm, P = 0.009),但病变程度相当(75.8%的磁共振成像组vs 82.9%的无磁共振成像组,P = 0.26)。即使按乳腺密度(P = 0.76)、pT2肿瘤大小(P = 0.35)或小叶癌组织学表现(P = 0.26)分层,两组的再手术率相似(磁共振成像组19.1% vs无磁共振成像组17.6%,P = 0.91)。47例术前mri行乳房切除术的患者中有12例(25.5%)发现病理上可避免的乳房切除术(多灶或多中心MR成像和单灶组织病理学发现)。结论:术前选择性使用磁共振成像来减少乳腺癌患者的再手术,这些数据不支持。在相当数量的患者中,MR成像高估了疾病的程度。
{"title":"Selective preoperative magnetic resonance imaging in women with breast cancer: no reduction in the reoperation rate.","authors":"Joseph J Weber,&nbsp;Lisa S Bellin,&nbsp;David E Milbourn,&nbsp;Kathryn M Verbanac,&nbsp;Jan H Wong","doi":"10.1001/archsurg.2012.1660","DOIUrl":"https://doi.org/10.1001/archsurg.2012.1660","url":null,"abstract":"<p><strong>Hypothesis: </strong>The use of preoperative magnetic resonance (MR) imaging may have an effect on the reoperation rate in women with operable breast cancer.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Setting: </strong>University medical center.</p><p><strong>Patients: </strong>Women with operable breast cancer treated by a single surgeon between January 1, 2006, and December 31, 2010.</p><p><strong>Intervention: </strong>Selective preoperative MR imaging based on breast density and histologic findings.</p><p><strong>Main outcome measures: </strong>Reoperation rate and pathologically avoidable mastectomy at initial operation.</p><p><strong>Results: </strong>Of 313 patients in the study, 120 underwent preoperative MR imaging. Patients undergoing MR imaging were younger (mean age, 53.6 vs 59.5 years; P < .001), were more often of non-Hispanic white race/ethnicity (61.7% vs 52.3%, P < .05), and more likely had heterogeneously dense or very dense breasts (68.4% vs 22.3%, P < .001). The incidence of lobular carcinoma (8.3% in the MR imaging group vs 5.2% in the no MR imaging group, P = .27) and the type of surgery performed (mastectomy vs partial mastectomy, P = .67) were similar in both groups. The mean pathological size of the index tumor in the MR imaging group was larger than that in the no MR imaging group (2.02 vs 1.72 cm, P = .009), but the extent of disease was comparable (75.8% in the MR imaging group vs 82.9% in the no MR imaging group had pathologically localized disease, P = .26). The reoperation rate was similar between the 2 groups (19.1% in the MR imaging group vs 17.6% in the no MR imaging group, P = .91) even when stratified by breast density (P = .76), pT2 tumor size (P = .35), or lobular carcinoma histologic findings (P = .26). Pathologically avoidable mastectomy (multifocal or multicentric MR imaging and unifocal histopathological findings) was observed in 12 of 47 patients (25.5%) with preoperative MR imaging who underwent mastectomy.</p><p><strong>Conclusion: </strong>The selective use of preoperative MR imaging to decrease reoperation in women with breast cancer is not supported by these data. In a considerable number of patients, MR imaging overestimates the extent of disease.</p>","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":"834-9"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archsurg.2012.1660","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30912638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
Umbilical hernia repair in patients with signs of portal hypertension: surgical outcome and predictors of mortality. 有门静脉高压症征象的脐疝修补术:手术结果和死亡率的预测因素。
Pub Date : 2012-09-01 DOI: 10.1001/archsurg.2012.1663
Sung W Cho, Neil Bhayani, Pippa Newell, Maria A Cassera, Chet W Hammill, Ronald F Wolf, Paul D Hansen

Objectives: To compare the outcomes of umbilical hernia repair in patients with and without signs of portal hypertension, such as esophageal varices or ascites; to assess the effect of emergency surgery on complication rates; and to identify predictors of postoperative mortality.

Design: Database search from January 1, 2005, through December 31, 2009.

Setting: North American hospitals participating in the American College of Surgeons National Surgical Quality Improvement Program initiative.

Patients: We studied patients who underwent umbilical hernia repair. Those with congestive heart failure, disseminated malignant tumor, or chronic renal failure while undergoing dialysis were excluded.

Main outcome measures: Preoperative variables and perioperative course were analyzed. Main outcome measures were morbidity and mortality after umbilical hernia repair.

Results: A total of 390 patients with ascites and/or esophageal varices formed the study group, and the remaining 22 952 patients formed the control group. The overall morbidity and mortality rates for the study group were 13.1% and 5.1%, whereas these rates were 3.9% and 0.1% for the control group, respectively (P < .001). For the study group, the mortality after elective repair among patients with a model for end-stage liver disease (MELD) score greater than 15 was 11.1% compared with 1.3% in patients with a MELD score of 15 or less. The patients with ascites and/or esophageal varices underwent emergency surgery more frequently than the control group (37.7% vs 4.9%; P < .001). Emergency surgery for the study group was associated with a higher morbidity than elective surgery (20.8% vs 8.3%; P < .001) but not a significantly higher mortality (7.4% vs 3.7%; P = .11). However, logistic regression analysis showed that age older than 65 years, MELD score higher than 15, albumin level less than 3.0 g/dL (to convert to grams per liter, multiply by 10), and sepsis at presentation were more predictive of postoperative mortality.

Conclusions: Umbilical hernia repair in the presence of ascites and/or esophageal varices is associated with significant postoperative complication rates. Emergency surgery is associated with higher morbidity rates but not significantly higher mortality rates. Elective repair of umbilical hernia should be avoided for those with adverse predictors, such as age older than 65 years, MELD score higher than 15, and albumin level less than 3.0 g/dL.

目的:比较有和无门静脉曲张或腹水等门静脉高压症患者脐疝修复的结果;评估急诊手术对并发症发生率的影响;并确定术后死亡率的预测因素。设计:从2005年1月1日到2009年12月31日的数据库搜索。环境:参与美国外科医师学会国家手术质量改进计划倡议的北美医院。患者:我们研究了接受脐疝修补术的患者。排除有充血性心力衰竭、播散性恶性肿瘤或慢性肾衰竭的患者。主要观察指标:分析术前变量及围手术期过程。主要观察指标为脐疝修补术后的发病率和死亡率。结果:共有390例腹水和/或食管静脉曲张患者组成研究组,其余22 952例患者组成对照组。研究组的总发病率和死亡率分别为13.1%和5.1%,而对照组的总发病率和死亡率分别为3.9%和0.1% (P < 0.001)。在研究组中,终末期肝病模型(MELD)评分大于15的患者择期修复后的死亡率为11.1%,而MELD评分小于等于15的患者择期修复后的死亡率为1.3%。腹水和/或食管静脉曲张患者接受急诊手术的频率高于对照组(37.7% vs 4.9%;P < 0.001)。研究组急诊手术的发病率高于择期手术(20.8% vs 8.3%;P < 0.001),但死亡率没有显著升高(7.4% vs 3.7%;P = .11)。然而,logistic回归分析显示,年龄大于65岁,MELD评分高于15,白蛋白水平低于3.0 g/dL(换算成克/升,乘以10),就诊时败血症更能预测术后死亡率。结论:存在腹水和/或食管静脉曲张的脐疝修补术与显著的术后并发症发生率相关。急诊手术与较高的发病率相关,但与较高的死亡率无关。对于有不良预测因素的患者,如年龄大于65岁、MELD评分高于15分、白蛋白水平低于3.0 g/dL的患者,应避免选择脐疝修补术。
{"title":"Umbilical hernia repair in patients with signs of portal hypertension: surgical outcome and predictors of mortality.","authors":"Sung W Cho,&nbsp;Neil Bhayani,&nbsp;Pippa Newell,&nbsp;Maria A Cassera,&nbsp;Chet W Hammill,&nbsp;Ronald F Wolf,&nbsp;Paul D Hansen","doi":"10.1001/archsurg.2012.1663","DOIUrl":"https://doi.org/10.1001/archsurg.2012.1663","url":null,"abstract":"<p><strong>Objectives: </strong>To compare the outcomes of umbilical hernia repair in patients with and without signs of portal hypertension, such as esophageal varices or ascites; to assess the effect of emergency surgery on complication rates; and to identify predictors of postoperative mortality.</p><p><strong>Design: </strong>Database search from January 1, 2005, through December 31, 2009.</p><p><strong>Setting: </strong>North American hospitals participating in the American College of Surgeons National Surgical Quality Improvement Program initiative.</p><p><strong>Patients: </strong>We studied patients who underwent umbilical hernia repair. Those with congestive heart failure, disseminated malignant tumor, or chronic renal failure while undergoing dialysis were excluded.</p><p><strong>Main outcome measures: </strong>Preoperative variables and perioperative course were analyzed. Main outcome measures were morbidity and mortality after umbilical hernia repair.</p><p><strong>Results: </strong>A total of 390 patients with ascites and/or esophageal varices formed the study group, and the remaining 22 952 patients formed the control group. The overall morbidity and mortality rates for the study group were 13.1% and 5.1%, whereas these rates were 3.9% and 0.1% for the control group, respectively (P < .001). For the study group, the mortality after elective repair among patients with a model for end-stage liver disease (MELD) score greater than 15 was 11.1% compared with 1.3% in patients with a MELD score of 15 or less. The patients with ascites and/or esophageal varices underwent emergency surgery more frequently than the control group (37.7% vs 4.9%; P < .001). Emergency surgery for the study group was associated with a higher morbidity than elective surgery (20.8% vs 8.3%; P < .001) but not a significantly higher mortality (7.4% vs 3.7%; P = .11). However, logistic regression analysis showed that age older than 65 years, MELD score higher than 15, albumin level less than 3.0 g/dL (to convert to grams per liter, multiply by 10), and sepsis at presentation were more predictive of postoperative mortality.</p><p><strong>Conclusions: </strong>Umbilical hernia repair in the presence of ascites and/or esophageal varices is associated with significant postoperative complication rates. Emergency surgery is associated with higher morbidity rates but not significantly higher mortality rates. Elective repair of umbilical hernia should be avoided for those with adverse predictors, such as age older than 65 years, MELD score higher than 15, and albumin level less than 3.0 g/dL.</p>","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":"864-9"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archsurg.2012.1663","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30913667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 63
Is palpation in the operating room the best method for surgical planning? 在手术室触诊是手术计划的最佳方法吗?
Pub Date : 2012-09-01 DOI: 10.1001/archsurg.2012.2165
Richard J Bold
Surgical resection of isolated pulmonary metastatic melanoma improves overall survival in a highly select group of patients. However, the devil is in the details. By that, I mean that a critical examination of how these “selected” patients are identified needs to be made to ensure a benefit from the surgical intervention while sparing those patients with poor outcomes the complications of a thoracic operation. Peterson et al 1 reported a series of more than 1700 patients with pulmonary metastasis from cutaneous melanoma; less than 20% underwent resection of the metastatic disease to the lung. From this and other studies, those patients most likely to benefit harbor solitary lesions; furthermore, incomplete resection offers minimal improvement in survival. Chua et al 2 recently reported a single-institution series of 292 consecutive patients; the median survival for patients undergoing resection of a solitary melanoma metastasis was 35 months, decreasing to 21 months for 2 or 3 melanoma metastases and 10 months for more than 3 distinct lesions, 2 which is not different from the median survival of 8 months for those patients who did not undergo resection of pulmonary metastatic melanoma. 1 Therefore, the preoperative selection of patients is essential to identify those patients most likely to benefit from thoracic surgery and to spare an unnecessary and potentially morbid operation for those who will not benefit. In the current series 3 reported from the group at the John Wayne Cancer Institute in Santa Monica, California,reportedinthisissueofArchives,26%ofpatientstaken to the operating room for a thoracic resection of pulmonary melanoma metastases have more lesions than anticipated based on preoperative imaging using contrastenhancedcomputedtomography.Theseadditionallesions were small (median size of 5 mm) and located in a different lobe than the index lesion in one-third of patients. Although Kidner et al 3 recommend caution when considering a thoracoscopic approach (because the additional lesions were identified by palpation or visual inspection), their data are really a plea for better preoperative imaging for more accurate patient selection. As additional unsuspected lesions are identified during the exploratory phase of the operation, the benefits of resection start to decrease. Although resection of all palpable or noticeable melanomas may seem a surgical success, biologywilltriumphattheendoftheday.Wemuststrive to move from “selected” patients for surgical procedures to “accurately and individually selected” patients. Until then, a surgeon’s hands may be the best tool to facilitate surgical planning.
{"title":"Is palpation in the operating room the best method for surgical planning?","authors":"Richard J Bold","doi":"10.1001/archsurg.2012.2165","DOIUrl":"https://doi.org/10.1001/archsurg.2012.2165","url":null,"abstract":"Surgical resection of isolated pulmonary metastatic melanoma improves overall survival in a highly select group of patients. However, the devil is in the details. By that, I mean that a critical examination of how these “selected” patients are identified needs to be made to ensure a benefit from the surgical intervention while sparing those patients with poor outcomes the complications of a thoracic operation. Peterson et al 1 reported a series of more than 1700 patients with pulmonary metastasis from cutaneous melanoma; less than 20% underwent resection of the metastatic disease to the lung. From this and other studies, those patients most likely to benefit harbor solitary lesions; furthermore, incomplete resection offers minimal improvement in survival. Chua et al 2 recently reported a single-institution series of 292 consecutive patients; the median survival for patients undergoing resection of a solitary melanoma metastasis was 35 months, decreasing to 21 months for 2 or 3 melanoma metastases and 10 months for more than 3 distinct lesions, 2 which is not different from the median survival of 8 months for those patients who did not undergo resection of pulmonary metastatic melanoma. 1 Therefore, the preoperative selection of patients is essential to identify those patients most likely to benefit from thoracic surgery and to spare an unnecessary and potentially morbid operation for those who will not benefit. In the current series 3 reported from the group at the John Wayne Cancer Institute in Santa Monica, California,reportedinthisissueofArchives,26%ofpatientstaken to the operating room for a thoracic resection of pulmonary melanoma metastases have more lesions than anticipated based on preoperative imaging using contrastenhancedcomputedtomography.Theseadditionallesions were small (median size of 5 mm) and located in a different lobe than the index lesion in one-third of patients. Although Kidner et al 3 recommend caution when considering a thoracoscopic approach (because the additional lesions were identified by palpation or visual inspection), their data are really a plea for better preoperative imaging for more accurate patient selection. As additional unsuspected lesions are identified during the exploratory phase of the operation, the benefits of resection start to decrease. Although resection of all palpable or noticeable melanomas may seem a surgical success, biologywilltriumphattheendoftheday.Wemuststrive to move from “selected” patients for surgical procedures to “accurately and individually selected” patients. Until then, a surgeon’s hands may be the best tool to facilitate surgical planning.","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":"875"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archsurg.2012.2165","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30913669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appropriate surgical procedure for dominant thyroid nodules of the isthmus 1 cm or larger. 对于大于1厘米的峡部显性甲状腺结节,应采取适当的手术治疗。
Pub Date : 2012-09-01 DOI: 10.1001/archsurg.2012.728
Melanie Goldfarb, Steven S Rodgers, John I Lew

Hypothesis: Surgeon-performed ultrasound (SUS) and fine-needle aspiration (FNA) may guide the management of dominant thyroid nodules of the isthmus.

Design: Retrospective review of prospectively collected data.

Setting: Tertiary academic referral center.

Patients: Of 942 patients who underwent preoperative SUS and FNA, followed by thyroidectomy, between January 1, 2002, and April 10, 2010, a total of 28 patients had a dominant thyroid nodule of the isthmus.

Main outcome measures: Preoperative SUS features and FNA findings and final pathologic results.

Results: Of 28 patients (3%) who had a dominant thyroid nodule of the isthmus, 16 had benign final pathologic results, with all having at least 2 benign SUS features and 9 having 3 benign SUS features; 15 of 16 patients had an FNA finding that was benign or indeterminate. Of 12 patients with malignant final pathologic results, 8 had 3 malignant SUS features, and all had an FNA finding that was malignant or suspicious for a malignant neoplasm. Among these 12 patients, final pathologic results demonstrated multifocal disease (8 patients), extracapsular invasion (4 patients), or lymph node involvement (7 patients). When 11 patients with a malignant dominant thyroid nodule of the isthmus were compared with an overall group of 270 other well-differentiated papillary thyroid carcinomas 1 cm or larger on final pathologic results, patients with isthmus nodules trended toward having higher rates of multifocal disease (P = .08), extracapsular invasion (P = .09), and lymph node involvement (P = .09).

Conclusions: Preoperative SUS features and FNA findings in patients with dominant thyroid nodules of the isthmus can accurately predict malignant or benign thyroid disease and direct the extent of thyroidectomy. For malignant isthmus nodules, total thyroidectomy and possible central node dissection are recommended owing to high rates of multifocal disease and lymph node involvement. For benign isthmus nodules, thyroid lobectomy with isthmusectomy or isthmusectomy alone may be appropriate.

假设:外科超声(SUS)和细针抽吸(FNA)可以指导峡部显性甲状腺结节的治疗。设计:对前瞻性收集的数据进行回顾性分析。单位:三级学术转诊中心。患者:在2002年1月1日至2010年4月10日期间,942例术前行SUS和FNA并行甲状腺切除术的患者中,共有28例患者在峡部有显性甲状腺结节。主要观察指标:术前SUS特征、FNA检查结果及最终病理结果。结果:峡部显性甲状腺结节的28例(3%)患者中,16例最终病理结果为良性,所有患者均至少有2个SUS良性特征,9例有3个SUS良性特征;16例患者中有15例FNA发现为良性或不确定。在12例最终病理结果为恶性的患者中,8例有3个恶性SUS特征,所有患者的FNA检查结果均为恶性或怀疑为恶性肿瘤。在这12例患者中,最终病理结果显示多灶性疾病(8例)、囊外浸润(4例)或淋巴结受累(7例)。当11例峡部恶性显性甲状腺结节患者与270例其他1厘米或更大的分化良好的甲状腺乳头状癌患者的最终病理结果进行比较时,峡部结节患者倾向于多灶性疾病(P = 0.08)、囊外浸润(P = 0.09)和淋巴结累及(P = 0.09)的发生率更高。结论:峡部显性甲状腺结节患者术前SUS特征及FNA表现可准确预测甲状腺良恶性病变,指导甲状腺切除术的范围。对于恶性峡部结节,由于多灶性疾病和淋巴结累及的高发生率,建议全甲状腺切除术和可能的中央淋巴结清扫。对于良性峡部结节,甲状腺小叶切除联合峡部切除或单独峡部切除可能是合适的。
{"title":"Appropriate surgical procedure for dominant thyroid nodules of the isthmus 1 cm or larger.","authors":"Melanie Goldfarb,&nbsp;Steven S Rodgers,&nbsp;John I Lew","doi":"10.1001/archsurg.2012.728","DOIUrl":"https://doi.org/10.1001/archsurg.2012.728","url":null,"abstract":"<p><strong>Hypothesis: </strong>Surgeon-performed ultrasound (SUS) and fine-needle aspiration (FNA) may guide the management of dominant thyroid nodules of the isthmus.</p><p><strong>Design: </strong>Retrospective review of prospectively collected data.</p><p><strong>Setting: </strong>Tertiary academic referral center.</p><p><strong>Patients: </strong>Of 942 patients who underwent preoperative SUS and FNA, followed by thyroidectomy, between January 1, 2002, and April 10, 2010, a total of 28 patients had a dominant thyroid nodule of the isthmus.</p><p><strong>Main outcome measures: </strong>Preoperative SUS features and FNA findings and final pathologic results.</p><p><strong>Results: </strong>Of 28 patients (3%) who had a dominant thyroid nodule of the isthmus, 16 had benign final pathologic results, with all having at least 2 benign SUS features and 9 having 3 benign SUS features; 15 of 16 patients had an FNA finding that was benign or indeterminate. Of 12 patients with malignant final pathologic results, 8 had 3 malignant SUS features, and all had an FNA finding that was malignant or suspicious for a malignant neoplasm. Among these 12 patients, final pathologic results demonstrated multifocal disease (8 patients), extracapsular invasion (4 patients), or lymph node involvement (7 patients). When 11 patients with a malignant dominant thyroid nodule of the isthmus were compared with an overall group of 270 other well-differentiated papillary thyroid carcinomas 1 cm or larger on final pathologic results, patients with isthmus nodules trended toward having higher rates of multifocal disease (P = .08), extracapsular invasion (P = .09), and lymph node involvement (P = .09).</p><p><strong>Conclusions: </strong>Preoperative SUS features and FNA findings in patients with dominant thyroid nodules of the isthmus can accurately predict malignant or benign thyroid disease and direct the extent of thyroidectomy. For malignant isthmus nodules, total thyroidectomy and possible central node dissection are recommended owing to high rates of multifocal disease and lymph node involvement. For benign isthmus nodules, thyroid lobectomy with isthmusectomy or isthmusectomy alone may be appropriate.</p>","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":"881-4"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archsurg.2012.728","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30913672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 35
Image of the month-quiz case. 月考案例图片。
Pub Date : 2012-09-01 DOI: 10.1001/archsurg.2011.1283a
Jeniann A Yi, Clay Cothren Burlew, Carlton C Barnett, Ernest E Moore
{"title":"Image of the month-quiz case.","authors":"Jeniann A Yi,&nbsp;Clay Cothren Burlew,&nbsp;Carlton C Barnett,&nbsp;Ernest E Moore","doi":"10.1001/archsurg.2011.1283a","DOIUrl":"https://doi.org/10.1001/archsurg.2011.1283a","url":null,"abstract":"","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archsurg.2011.1283a","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32400039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Benchmarks for international surgery. 国际手术的基准。
Pub Date : 2012-09-01 DOI: 10.1001/archsurg.2012.696
Anji E Wall
{"title":"Benchmarks for international surgery.","authors":"Anji E Wall","doi":"10.1001/archsurg.2012.696","DOIUrl":"https://doi.org/10.1001/archsurg.2012.696","url":null,"abstract":"","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":"796-7"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archsurg.2012.696","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30912757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
NSQIP lite: a potential tool for global comparative effectiveness evaluations. NSQIP寿命:一个潜在的全球比较有效性评估工具。
Pub Date : 2012-09-01 DOI: 10.1001/archsurg.2012.899
Diana L Farmer
{"title":"NSQIP lite: a potential tool for global comparative effectiveness evaluations.","authors":"Diana L Farmer","doi":"10.1001/archsurg.2012.899","DOIUrl":"https://doi.org/10.1001/archsurg.2012.899","url":null,"abstract":"","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":"803-4"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archsurg.2012.899","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30912630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Should a patient with cirrhosis have an innie or an outie? 肝硬化患者应该有内窥镜还是外窥镜?
Pub Date : 2012-09-01 DOI: 10.1001/archsurg.2012.2031
Linda L Wong
{"title":"Should a patient with cirrhosis have an innie or an outie?","authors":"Linda L Wong","doi":"10.1001/archsurg.2012.2031","DOIUrl":"https://doi.org/10.1001/archsurg.2012.2031","url":null,"abstract":"","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":"869-70"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archsurg.2012.2031","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30913668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Risk of advanced papillary thyroid cancer in obese patients. 肥胖患者晚期甲状腺乳头状癌的风险。
Pub Date : 2012-09-01 DOI: 10.1001/archsurg.2012.713
Avital Harari, Brandon Endo, Stacie Nishimoto, Philip H G Ituarte, Michael W Yeh

OBJECTIVE To determine whether increasing body mass index (BMI) is associated with more aggressive disease and adverse surgical outcomes in patients with papillary thyroid cancer (PTC). DESIGN Retrospective review of a prospective database. SETTING Single academic tertiary care center. PATIENTS A total of 443 patients older than 18 years who underwent total thyroidectomy for PTC from January 1, 2004, through March 31, 2011, were included in the analysis. Patients were organized into 4 BMI (calculated as weight in kilograms divided by height in meters squared) groups: normal (18.5-24.9), overweight (25-29.9), obese (30-39.9), and morbidly obese (≥40). MAIN OUTCOME MEASURES Disease stage at presentation, histologic subtype, duration of anesthetic induction and extubation, duration of surgery, surgical complications, length of hospital stay, and American Society of Anesthesiologists (ASA) class. RESULTS Ages ranged from 18 to 89 years. Greater BMI was associated with more advanced disease stage at presentation (P < .001) and more aggressive PTC histopathologic subtype (P = .03). Morbidly obese patients presented more frequently with stage III or IV disease (odds ratio, 3.67; P < .001). Greater BMI was also associated with longer duration of anesthetic induction (P < .001), increased length of stay (P < .001), and higher ASA class (P < .001). Duration of surgery was not associated with BMI. There was a trend toward larger tumors with increasing BMI (P = .06). Obese BMI was associated with more preoperative vocal cord paralysis due to local invasion (odds ratio, 9.21; P = .001). CONCLUSIONS Obese patients present with more advanced stage and more aggressive forms of PTC. This finding suggests that obese patients should be screened for thyroid cancer.

目的探讨甲状腺乳头状癌(PTC)患者身体质量指数(BMI)升高是否与疾病侵袭性增强和手术预后不良相关。设计前瞻性数据库的回顾性分析。单一学术三级医疗中心。从2004年1月1日至2011年3月31日,共有443名18岁以上因PTC接受甲状腺全切除术的患者被纳入分析。将患者分为4组BMI(以体重(公斤)除以身高(米)的平方):正常(18.5-24.9)、超重(25-29.9)、肥胖(30-39.9)和病态肥胖(≥40)。主要观察指标:发病分期、组织学亚型、麻醉诱导和拔管持续时间、手术持续时间、手术并发症、住院时间和美国麻醉医师学会(ASA)分级。结果患者年龄18 ~ 89岁。BMI越高,疾病病程越晚(P <.001)和更具侵袭性的PTC组织病理亚型(P = .03)。病态肥胖患者更常出现III期或IV期疾病(优势比,3.67;P & lt;措施)。BMI越大,麻醉诱导持续时间越长(P <.001),住院时间增加(P <.001), ASA等级较高(P <措施)。手术时间与BMI无关。BMI越高,肿瘤越大(P = 0.06)。肥胖BMI与术前声带局部浸润麻痹相关(优势比,9.21;p = .001)。结论肥胖患者的PTC表现为更晚期和更具侵袭性的形式。这一发现表明肥胖患者应该接受甲状腺癌筛查。
{"title":"Risk of advanced papillary thyroid cancer in obese patients.","authors":"Avital Harari,&nbsp;Brandon Endo,&nbsp;Stacie Nishimoto,&nbsp;Philip H G Ituarte,&nbsp;Michael W Yeh","doi":"10.1001/archsurg.2012.713","DOIUrl":"https://doi.org/10.1001/archsurg.2012.713","url":null,"abstract":"<p><p>OBJECTIVE To determine whether increasing body mass index (BMI) is associated with more aggressive disease and adverse surgical outcomes in patients with papillary thyroid cancer (PTC). DESIGN Retrospective review of a prospective database. SETTING Single academic tertiary care center. PATIENTS A total of 443 patients older than 18 years who underwent total thyroidectomy for PTC from January 1, 2004, through March 31, 2011, were included in the analysis. Patients were organized into 4 BMI (calculated as weight in kilograms divided by height in meters squared) groups: normal (18.5-24.9), overweight (25-29.9), obese (30-39.9), and morbidly obese (≥40). MAIN OUTCOME MEASURES Disease stage at presentation, histologic subtype, duration of anesthetic induction and extubation, duration of surgery, surgical complications, length of hospital stay, and American Society of Anesthesiologists (ASA) class. RESULTS Ages ranged from 18 to 89 years. Greater BMI was associated with more advanced disease stage at presentation (P &lt; .001) and more aggressive PTC histopathologic subtype (P = .03). Morbidly obese patients presented more frequently with stage III or IV disease (odds ratio, 3.67; P &lt; .001). Greater BMI was also associated with longer duration of anesthetic induction (P &lt; .001), increased length of stay (P &lt; .001), and higher ASA class (P &lt; .001). Duration of surgery was not associated with BMI. There was a trend toward larger tumors with increasing BMI (P = .06). Obese BMI was associated with more preoperative vocal cord paralysis due to local invasion (odds ratio, 9.21; P = .001). CONCLUSIONS Obese patients present with more advanced stage and more aggressive forms of PTC. This finding suggests that obese patients should be screened for thyroid cancer.</p>","PeriodicalId":8298,"journal":{"name":"Archives of Surgery","volume":"147 9","pages":"805-11"},"PeriodicalIF":0.0,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/archsurg.2012.713","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30852734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 49
期刊
Archives of Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1